drugset

drugset / Trial / NCT04970446

Microbial Restoration in Inflammatory Bowel Diseases

NCT04970446 ↗

Phase 1/2 Recruiting 120 enrolled St Vincent's Hospital Melbourne BiomeBank Adelaide · collab Monash University · collab The Queen Elizabeth Hospital · collab The University of Queensland · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a prospective, two-centre, double-blind, parallel-arm, randomised, placebo-controlled trial evaluating the impact of FMT on patients with active Crohn's disease.

Timeline

Start: 2022-05-01
Primary completion: 2025-04-01
Completion: 2026-04-01

Publications

Fehily SR, Wright EK, Basnayake C, Wilson-O'Brien AL, Stanley A, Marks EP, Russell EE, Hamilton AL, Bryant RV, Costello SP, Kamm MA. Faecal microbiota transplantation in Crohn's disease: an Australian randomised placebo-controlled trial protocol. BMJ Open. 2025 Apr 19;15(4):e094714. doi: 10.1136/bmjopen-2024-094714.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	faecal microbiota transplantation	Other / unclassified	—	Other

Indications